Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Ms. Rona S. AnhaltChief HR Officer | -2,24k | 13,04k | Derivative Exercise and Sale | 5,82 | 16,79k | - |
| 2026-06-01 | Ms. Rona S. AnhaltChief HR Officer | 4,91k | 0,00 | Derivative Exercise and Retained Stock | - | 16,79k | 41,29% |
| 2026-06-01 | Mr. Daniel D. CorcoranSenior VP, General Counsel & Secretary | -12,10k | 70,44k | Derivative Exercise and Sale | 5,82 | 32,05k | - |
| 2026-06-01 | Mr. Daniel D. CorcoranSenior VP, General Counsel & Secretary | 10,73k | 0,00 | Derivative Exercise and Retained Stock | - | 32,05k | 50,32% |
| 2026-05-14 | Ms. Cynthia L. CollinsInitié | 15,76k | 0,00 | Derivative Exercise and Retained Stock | - | 51,85k | 43,66% |
| 2026-05-14 | Dr. John V. W. ReyndersIndependent Director | 15,76k | 0,00 | Derivative Exercise and Retained Stock | - | 26,47k | 147,14% |
| 2026-05-14 | Mr. Eran BroshyIndependent Director | 15,76k | 0,00 | Derivative Exercise and Retained Stock | - | 50,71k | 45,08% |
| 2026-05-14 | Arjun BediInitié | 5,55k | 0,00 | Derivative Exercise and Retained Stock | - | 5,55k | - |
| 2026-05-14 | Mr. James E. CashmanIndependent Chairman of the Board | 15,76k | 0,00 | Derivative Exercise and Retained Stock | - | 484,20k | 3,36% |
| 2026-05-14 | Ms. Nancy KilleferIndependent Director | 15,76k | 0,00 | Derivative Exercise and Retained Stock | - | 51,85k | 43,66% |
| 2026-05-14 | Mr. Matthew M. WalshIndependent Director | 15,76k | 0,00 | Derivative Exercise and Retained Stock | - | 213,32k | 7,98% |
| 2026-05-14 | Ms. Rosemary A. CraneInitié | 15,76k | 0,00 | Derivative Exercise and Retained Stock | - | 45,67k | 52,67% |
| 2026-05-11 | Mr. Jon ResnickCEO & Director | -24,38k | 153,82k | Derivative Exercise and Sale | 6,31 | 35,39k | - |
| 2026-05-11 | Mr. Jon ResnickCEO & Director | 35,39k | 0,00 | Derivative Exercise and Retained Stock | - | 35,39k | - |
| 2026-04-01 | Mr. Leif E. PedersenPresident & Chief Commercial Officer | 25,09k | 0,00 | Derivative Exercise and Retained Stock | - | 110,05k | 29,53% |
| 2026-04-01 | Mr. Leif E. PedersenPresident & Chief Commercial Officer | -8,08k | 46,04k | Derivative Exercise and Sale | 5,70 | 110,05k | - |
| 2026-04-01 | Mr. Leif E. PedersenPresident & Chief Commercial Officer | -3,53k | 20,14k | Sale to Issuer | 5,70 | 110,05k | -3,11% |
| 2026-04-01 | Dr. Adrian K. McKemeyPresident of Drug Development Solutions | 8,21k | 0,00 | Derivative Exercise and Retained Stock | - | 8,21k | - |
| 2026-04-01 | Dr. Adrian K. McKemeyPresident of Drug Development Solutions | -2,64k | 15,06k | Derivative Exercise and Sale | 5,70 | 8,21k | - |
| 2026-04-01 | Mr. Daniel D. CorcoranSenior VP, General Counsel & Secretary | 5,10k | 0,00 | Derivative Exercise and Retained Stock | - | 21,32k | 31,43% |
| 2026-04-01 | Mr. Daniel D. CorcoranSenior VP, General Counsel & Secretary | -5,75k | 32,78k | Derivative Exercise and Sale | 5,70 | 21,32k | - |
| 2026-04-01 | Mr. John E. GallagherSVP, Principal Accounting Officer & CFO | 33,27k | 0,00 | Derivative Exercise and Retained Stock | - | 95,37k | 53,58% |
| 2026-04-01 | Mr. John E. GallagherSVP, Principal Accounting Officer & CFO | -17,33k | 74,13k | Derivative Exercise and Sale | 5,70 | 95,37k | - |
| 2026-04-01 | Mr. John E. GallagherSVP, Principal Accounting Officer & CFO | -7,78k | 44,32k | Sale to Issuer | 5,70 | 95,37k | -7,54% |
| 2026-04-01 | Dr. Robert P. AspburyPresident of Certara Predictive Technologies | 17,58k | 0,00 | Derivative Exercise and Retained Stock | - | 332,44k | 5,58% |
| 2026-04-01 | Dr. Robert P. AspburyPresident of Certara Predictive Technologies | -15,59k | 88,86k | Derivative Exercise and Sale | 5,70 | 332,44k | - |
| 2026-04-01 | Dr. Robert P. AspburyPresident of Certara Predictive Technologies | -6,82k | 38,88k | Sale to Issuer | 5,70 | 332,44k | -2,01% |
| 2026-04-01 | Ms. Rona S. AnhaltChief HR Officer | 6,70k | 0,00 | Derivative Exercise and Retained Stock | - | 11,88k | 129,36% |
| 2026-04-01 | Ms. Rona S. AnhaltChief HR Officer | -3,06k | 17,45k | Derivative Exercise and Sale | 5,70 | 11,88k | - |
| 2025-11-11 | Dr. William F. FeeheryInitié | 24,10k | 200,00k | Achat | 8,30 | 2,36M | 1,03% |
| 2025-09-09 | Mr. Leif E. PedersenPresident & Chief Commercial Officer | -51,22k | 559,37k | Automatic Disposition | 10,92 | 73,98k | -40,91% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
